FGF23 and chronic kidney disease: These results demonstrated that an imbalance in α-Klotho/FGF23, myocardial hypertrophy, and fibrosis are more pronounced and accompanied by the up-regulation of β-catenin and TRPC/CaN/NFAT signaling in the settings of AH and CKD.